People: Roche Holding AG (RHHBY.PK)

RHHBY.PK on OTC(non-bulletin-board)

41.50USD
9 Feb 2010
Price Change (% chg)

$0.57 (+1.39%)
Prev Close
$40.93
Open
$41.15
Day's High
$41.68
Day's Low
$41.15
Volume
315,657
Avg. Vol
475,370
52-wk High
$45.19
52-wk Low
$26.01

view people for:

Summary

Name Age Since Current Position
Schwan, Severin 43 2008 Chairman of the Corporate Executive Committee, Chief Executive Officer
Humer, Franz 63 2008 Non-Executive Chairman of the Board of Directors
Gerber, Fritz 80 2004 Honorary Chairman of the Board
Hunziker, Erich 56 2005 Chief Financial Officer, Deputy Head of the Corporate Executive Committee
Hoffmann, Andre 51 Non-Executive Vice Chairman of the Board
Gehrig, Bruno 63 2008 Non-Executive Vice Chairman of the Board
Keller, Gottlieb 56 2008 Member of the Corporate Executive Committee, General Counsel, Head of Corporate Services, Secretary
Kissling, Rene 44 2007 Secretary to the Corporate Executive Committee
Ayyoubi, Silvia 57 2008 Member of the Corporate Executive Committee, Head of Corporate Human Resources
Soriot, Pascal 51 2010 Member of the Corporate Executive Committee, COO Pharmaceuticals Division, CEO of Genentech
O'Day, Daniel 46 2010 Corporate Executive Committee, COO of Diagnostics Division
Bell, John 57 2001 Non-Executive Director
Frey, Walter 66 2001 Non-Executive Director
De Vink, Lodewijk 64 2004 Non-Executive Director
Oeri, Andreas 60 1996 Non-Executive Director
Julius, DeAnne 60 2002 Non-Executive Director
Burns, William 62 2010 Non-Executive Director
Weder di Mauro, Beatrice 44 2006 Non-Executive Director
Baschera, Pius 59 2007 Non-Executive Director
Ruttenstorfer, Wolfgang 59 2007 Non-Executive Director
Levinson, Arthur 60 2010 Non-Executive Director
» Insider Trading

Biographies

Name Description
Schwan, Severin Dr. Severin Schwan has been Chairman of the Corporate Executive Committee and Chief Executive Officer of Roche Holding Ltd. since March 4, 2008. He was previously Chief Executive Officer of the Division Roche Diagnostics and Member of the Corporate Executive Committee at the Company from January 1, 2006. Dr. Schwan studied Economics at Universitaet Innsbruck, University of York and University of Oxford. He gained an Economics Degree from Innsbruck. He studied Law at the University of Innsbruck and gained a Law degree in 1991. Dr. Schwan then completed a Doctorate in Law at Universitaet Innsbruck in 1993 and Research studies at University Louvain, Belgium. From 1993 until 1995, he was a Trainee at Corporate Finance for Roche Basel. From 1995 until 1998, he was Head of Finance & Administration at Roche Brussels. From 1998 until 2000, Dr. Schwan was Head Finance & Informatics at Roche Grenzach, Germany and Member of the Executive Board of Roche Deutschland Holding GmbH. From 2000 until 2004, he was Head of Global Finance & Services at Roche Diagnostics, Basel. Since 2009, Dr. Schwan has been Member of the Board of Directors of Chugai Pharmaceuticals, Japan, and Member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC).
Humer, Franz Dr. Franz B. Humer has been Non-Executive Chairman of the Board of Directors of Roche Holding Ltd. since March 4, 2008. In addition, he acts as Chairman of the Presidium/Nomination Committee of the Company. From 2001 until March 4, 2008, Dr. Humer served as Chairman of the Corporate Executive Committee and Chief Executive Officer at Roche Holding Ltd.. He holds a Doctorate degree in Law from Universitaet Innsbruck and a Master of Business Administration degree from Institut Europeen d'Administration des Affaires (INSEAD). He also holds an Honorary Doctorate from the Faculty of Science, University of Basel. From 1971 until 1973, Dr. Humer worked for ICME Zurich. From 1973 until 1981, he worked for Schering Plough Corporation, where he was General Manager in Ecuador, the United Kingdom and Portugal. From 1981 until 1995, Dr. Humer worked for Glaxo Holdings plc as Area Manager, Southern Europe, Director of Marketing Development and Product Licensing, and Chief Operating Director. In 1995, he joined F. Hoffmann-La Roche Ltd as Member of the Board of Directors of the Roche Holding Ltd, Basel, and Head of the Pharmaceuticals Division. In 1996, he became Chief Operating Officer of F. Hoffmann-La Roche Ltd. In 1998, Dr. Humer became Chief Executive Officer Roche Holding Ltd. He is Member of the European Round Table of Industrialists (ERT), Member of the JPMorgan International Council, Board Member of Salzburg University and Member of the Advisory Board at Allianz AG. Furthermore, Dr. Humer occupies the position of Vice Chairman of the International Advisory Board at the International Center for Missing and Exploited Children, Non-Executive Chairman at Diageo Plc and Chairman at Humer Stiftung as well as INSEAD.
Gerber, Fritz Dr. Fritz Gerber has been Honorary Chairman of the Board at Roche Holding Ltd. since 2001. Between 2001 and 2004, he additionally acted as Company's Member of the Board of Directors. From 1978 to 1997 Dr. Gerber occupied the position of Chairman of the Board at Roche Holding Ltd. and was also active as Chief Executive Officer between 1978 and 1997. He studied at the University of Bern and graduated as Lawyer (LL.M) and was admitted to the bar. He is an Honorary Doctor of Natural Science of the University Basel, Switzerland. Dr. Gerber has worked in the Federal Department of Economic Affairs, Bern (now SECO). In 1958, he joined "Zuerich" Insurance Company (now Zurich Financial Services), where he became General Manager in 1969 and Chairman of the Management Board in 1974. From 1977 until 1991, Dr. Gerber was Chairman of the Board of Directors and Chief Executive Officer and from 1991 until 1995, he was Non-Executive Chairman of the Board of Directors. Since 1995, he has been Honorary Chairman of Zurich Financial Services. From 1978 until 1997, he was Chairman of the Board of Directors and Chief Executive Officer of F. Hoffmann-La Roche & Co. Ltd. (now: Roche Holding Ltd.). From 1978 until 2001, Dr. Gerber was Chairman of the Board of Directors and from 2001 until 2004, he was Member of the Board of Directors and Honorary Chairman. He has also served as Member of the Board of I.C.I. Switzerland from 1967 until 1991, Alusuisse, Zuerich from 1977 until 1981, Credit Suisse, Zuerich, from 1978 until 1996, Nestle, Vevey (Deputy Chairman of the Board) from 1981 until 2001, IBM Corporation, Armonk from 1989 until 1996 and Bank Sal. Oppenheim jr., Zurich from 1997 until 2005. He served as Chairman of the Paul Sacher Foundation for contemporary music until April 2006, was Member of the Executive Committee of the Lucerne Music Festival until 2004 and Member of the Orchesterakademie des Philharmonischen Orchesters Berlin until 2004. Dr. Gerber is also Honorary Chairman of the Fritz Gerber Foundation for talented young people.
Hunziker, Erich Dr. Erich Hunziker has been Chief Financial Officer and Deputy Head of the Corporate Executive Committee at Roche Holding Ltd. since January 1, 2005. He joined the Company in 2001 as Member of the Executive Committee and Chief Financial Officer. He holds a Doctorate (Ph.D.) degree in Industrial Engineering from Eidgenoessische Technische Hochschule Zuerich (ETH), which he earned in 1983. In 1978, Dr. Hunziker became Head of Assistants at the Institute of Management & Industrial Engineering ETH, Zurich. In 1980, he became Chairman of the Swiss Student Travel Office (SSR). In 1983, Dr. Hunziker became Vice President Group Strategy Pharmaceuticals at Corange Ltd., Switzerland (holding company Boehringer Mannheim Group). In 1988, he became Managing Director of Boehringer Mannheim, Switzerland. In 1992, he became Head of Finance and Member of the Executive Board of Boehringer Mannheim, Germany. In 1994, Dr. Hunziker became Head of Finance and Chairman of the Executive Board of Boehringer Mannheim, Germany. In 1995, he became President Pharmaceuticals Division and Member of the Executive Committee of Boehringer Mannheim Group, Netherlands. In 1997, Dr. Hunziker became Chief Financial Officer of Corange Ltd. in Bermuda and the United Kingdom. In 1998, he became Chief Executive Officer of the Diethelm Group, Switzerland. In 2000, he became Chief Executive Officer of Diethelm Keller Group, Switzerland. In 2004, he became Board Member of Genentech, United States of America (Roche Subsidiary). In 2006, Dr. Hunziker became Board Member of Chugai Pharmaceuticals, Japan (Roche Subsidiary). He also has a Board Membership at Holcim Ltd.
Hoffmann, Andre Mr. Andre Hoffmann is Non-Executive Vice Chairman of the Board of Directors at Roche Holding Ltd. Additionally, he acts as Member of the Presidium/Nomination Committee and Remuneration Committee of the Company. He joined the Company’s Board of Directors in 1996. From 1977 until 1978, he studied at Universite de Geneve and from 1979 until 1982 Mr. Hoffmann studied at St. Gallen School of. In 1990, he received a Master of Business Administration degree from Institut Europeen d’Administration des Affaires (INSEAD). From 1985 until 1989, he worked for James Capel and Co., where his latest position was Manager, European Mergers & Acquisitions. From 1991 until 1993, he worked for Nestle UK Ltd., where his latest position was Special Project Manager, Food division. Since 1994, Mr. Hoffmann has worked in Private Investment Activities. Since 2000, he has been Member of the Board of Givaudan Ltd., Member of the Board of Glyndebourne Productions Ltd., and Chairman of Nemadi Advisors Ltd. Since 2003, he has been Member of the Board of Brunswick Capital Ltd. and Chairman of Living Planet Fund Management Co. He is Vice President of WWF International, Treasurer of Fondation les Corbillettes pour l'Aide aux enfants handicapes mentaux, Member of the Executive Committee of IRP, Institut International de Recherche en Paraplegie, Founding Member of Stiftung Patronatskomitee Kunstmuseum Basel, Board Member of Roche Research Foundation, International Council Member of Tate Gallery, Chairman of the Board of Fondation Pro Valat, Vice Chairman of the Board of Fondation Sansouire, Board Member of Takh, Association pour le Cheval de Przewalski, President of FIBA, Fondation Internationale du Banc d'Arguin, Member of the Executive Committee of the International Institute for Strategic Studies, London, Member of the Court of Benefactors of Oxford University, Member of the Executive Committee of Paul Sacher Stiftung, Member of the Foundation Board of Fondation Dr Henri Dubois-Ferriere Dinu Lipatti and Board Member of Global Footprint Network.
Gehrig, Bruno Prof. Dr. Bruno Gehrig has been Non-Executive Vice Chairman of the Board of Directors of Roche Holding Ltd. since April 6, 2004. In addition, he acts as Chairman of the Remuneration Committee and as Member of the Presidium/Nomination Committee of the Company. Until March 4, 2008, he also served as Independent Lead Director of Roche Holding Ltd. from April 6, 2004. From 1989 until 1991, Prof. Dr. Gehrig occupied the position of Chairman of the Executive Board of Bank Cantrade Ltd., Zurich, with responsibility for the other parts of the group. From 1992 until 1996, he was active as Professor of Business Administration at the University of St. Gallen and Head of its Swiss Institute Banking and Finance. From 1996 until 2000, he was Member of the Governing Board of the Swiss National Bank. From 2001 until 2003, Prof. Dr. Gehrig was Vice Chairman of the Governing Board of the Swiss National Bank. Since July 2003, he has been Chairman of the Board of Directors of Swiss Life Holding. From 1971 until 1980, he was Assistant and, from 1978, Lecturer at the University of Bern. In 1975, he gained a Doctorate in Economics (Dr. rer. pol.) from Universitaet Bern. In 1978, Prof. Dr. Gehrig qualified as Lecturer at Universitaet Bern with a study on Monetary Policy, following studies with Prof. Karl Brunner at the University of Rochester. In 2006, he received an Honorary Doctorate of Laws from the University of Rochester. From 1984 until 1991, he was Chairman of the economic policy study group of the Christian Democratic Party (CVP) and from 1992 until 1996, he was Member of the Swiss Federal Banking Commission. Currently, Prof. Dr. Gehrig serves as Member of the Board of Trustees of Kartause Ittingen, Canton of Thurgau, Switzerland; Chairman of the Board of Trustees of the Swiss Air Transport Foundation; and Member of the Board of Trustees of the Foundation Antidoping Schweiz. Moreover, he is Member of the Board of Directors at UBS AG.
Keller, Gottlieb Dr. Gottlieb A. Keller has been Member of the Corporate Executive Committee, General Counsel, Head of Corporate Services and Secretary to the Board of Directors at Roche Holding Ltd. since March 5, 2008. He was previously Head of Human Resources and Corporate Services, as well as Secretary to the Board of Directors and Member of Corporate Executive Committee at the Company. In 1984, he joined the Corporate Law Department of the Roche Group. In 1989, he became Head of Business Development and Pharma Marketing Services of Roche Grenzach, Germany. In 1992, he became Assistant to the Chairman of the Board of Directors of Roche Holding Ltd. In 1996, he became Head of Human Resources at Hoffmann-La Roche Ltd, Germany. In 1998, he became Speaker of the Management Board of Hoffmann-La Roche Ltd, Germany. In 1999, he became Chairman of the Executive Board of Roche Deutschland Holding GmbH and then Secretary to the Board of Directors of Roche Holding Ltd and Corporate Compliance Officer of the Roche Group. In 2003, he became Member of the Corporate Executive Committee of the Roche Group and Head of Corporate Human Resources and Pharma Site Management in Basel and Kaiseraugst. In 2004, he became Head of Corporate Services and Human Resources. He studied Law and Economics at the University of Basel and gained a Doctor of Law (Dr. iur) in 1980. He was admitted as Attorney in 1981 and became Notary Public of Basel in 1984 (not practicing). He is Committee Member of VSUD, President of the Board of Crocodil AG, Member of the Chairman's Committee of the Chamber of Commerce Germany-Switzerland, Member of the Board of Trustees of the Fritz Gerber Foundation for talented young people, Member of the Board of Trustees of the Paul Sacher Foundation and Board Member of SGCI Chemie Pharma Schweiz and of economiesuisse. From 2003 until 2008, he was Board Member of the Basilea Pharmaceutica AG.
Kissling, Rene Mr. Rene Kissling has been Secretary to the Corporate Executive Committee at Roche Holding Ltd. since June 1, 2007. From September 1, 2003, he was Assistant to the Secretary to the Board of Directors of Roche Holding Ltd and Secretary to Board of Directors Committees of Roche Holding Ltd. From 2000 until 2003, he worked in the Corporate Law Department of the Roche Group. From 1999 until 2000 he was Legal Consultant and Attorney at Law of Coop Group. He completed studies in Law at the University of Basel in 1993 and was admitted as Attorney to the Bar of the City of Basel in 1998.
Ayyoubi, Silvia Ms. Silvia Ayyoubi has been Member of the Corporate Executive Committee and Head of Corporate Human Resources at Roche Holding Ltd. since March 5, 2008. She holds a Diploma in Commercial Economics from the Business School in Basel. From 1974, she worked for the Swiss Ministry of Foreign Affairs in Switzerland, Sweden, Egypt and Jordan. From 1986, she worked for Effifreight in Basel. From 1987, she worked for F. Hoffmann-La Roche Ltd in Basel as Public Relations Assistant, Pharma Communications. From 1989, she worked as Public Relations and Issue Manager. From 1991, she worked as Head of Executive Resource Planning Pharma in Corporate Human Resources. From 1996, she worked as Head of Executive Development in Corporate Human Resources. From 2001, she worked as Head of Global Human Resources in the Diagnostics Division.
Soriot, Pascal Mr. Pascal Soriot has been Member of the Corporate Executive Committee and Chief Executive Officer (CEO) of Genentech at Roche Holding Ltd. since April 2009, and Chief Operating Officer (COO) of Pharmaceuticals Division since Janaury 1, 2010. He holds a Master of Business Administration with major in Finance.
O'Day, Daniel Mr. Daniel O'Day has been Member of the Corporate Executive Committee and Chief Operating Officer (COO) of Diagnostics at Roche Holding Ltd. since Janaury 1, 2010.
Bell, John Prof. Sir John Irving Bell has been Non-Executive Director at Roche Holding Ltd. since 2001. In addition, he acts as Member of the Remuneration Committee of the Company. In 1975, he gained a Bachelor of Medical Science with Honors from the University of Alberta. In 1976, Prof. Sir Bell gained a Bachelor of Arts with Honors in Physiological Sciences from Magdalen College, Oxford University. In 1979, he gained a Bachelor of Medicine and Bachelor of Surgery (BM, BCh) from Magdalen College, Oxford University. In 1990, he gained a Doctor of Medicine (DM) from Magdalen College, Oxford University. From 1979 until 1982, he carried out postgraduate clinical training in Oxford and London. From 1982 until 1987, Prof. Sir Bell was Clinical Fellow in the Department of Medicine at Stanford University and also Postdoctoral Fellow in the Department of Medical Microbiology at Stanford University. From 1987 until 1989, he was Wellcome Senior Clinical Fellow and Honorary Consultant Physician in the Nuffield Departments of Clinical Medicine and Surgery at John Radcliffe Hospital, Oxford. From 1989 until 1992, he was University Lecturer at the Nuffield Department of Clinical Medicine at Oxford University. From 1992 until 2002, he was Nuffield Professor of Clinical Medicine at Oxford University. Since 2002, Prof. Sir Bell has been Regius Professor of Medicine at Oxford University. He is also has been Honorary Consultant Physician at Oxford Radcliffe NHS Trust since 1987; Nuffield Professor of Clinical Medicine Chairman at the Department of Medicine, Oxford University School of Medicine, since 1992; Founder of the Wellcome Trust Centre for Human Genetics since 1993; Chairman of the Partnership Board at the Oxford Centre for Diabetes, Endocrinology and Metabolism since 1999; Chairman of the Trials and Epidemiology Building, Oxford since 1999; and President of the Academy of Medical Sciences since 2006. In 2008, he was knighted in the 2008 Honors list for Services to Medicine.
Frey, Walter Mr. Walter Frey has been Non-Executive Director at Roche Holding Ltd. since 2001. He is Member of the Corporate Governance and Sustainability Committee as well as Audit Committee of the Company. Mr. Frey studied Business at Universitaet Zuerich and at London School of Economics. In 1966, he was Director at Emil Frey Ltd and in 1969, he was Chairman and Chief Executive Officer of the Emil Frey Group. From 1983 until 2003, he was Member of the Board of Zumtobel Staff AG. From 1987 until 2001, Mr. Frey was Member of the Swiss parliament. In 1997, he became President of the Board ZLE Betriebs AG. In 2001, he became Member of the Board of Allianz Suisse. In 2006, Mr. Frey became Member of the Board of Rhomberg Bau AG as well as Member of the Board of Rhomberg Bahntechnik AG. Furthermore, he was appointed Board Member of economiesuisse as of 2008.
De Vink, Lodewijk Mr. Lodewijk J.R. De Vink has been Non-Executive Director at Roche Holding Ltd. since May 6, 2004. In addition, he acts as Member of the Remuneration Committee of the Company. In 1968 Mr. De Vink earned a Bachelor of Business Administration degree from Washburn University and in 1969 a Master of Business Administration degree from American University. From 1969 until 1988, he worked for Schering-Plough/Schering International. From 1988 until 2000, he worked for Warner-Lambert Company, where Mr. De Vink was Chairman of the Board, President and Chief Executive Officer between 1999 and 2000. From 2000 until 2002, he was Chairman of Global Health Care Partners at Credit Suisse First Boston. From 2002 until 2003, Mr. De Vink was Chairman of International Health Care Partners. Since 2003, he has been Founding Member and Consultant at Blackstone Healthcare Partners, LLC. He studied Economy at the Netherlands School of Business and gained a B.B.A. from Washburn University in 1968 and an M.B.A. from the American University in 1969. He served as Board Member of Pharmaceutical Research and Manufacturers of America (PhRMA) where he was Chairman in 1995, The International Federation of Pharmaceutical Manufacturers Associations (IFPMA) where he was Chairman from 1998 until 1999, Trilateral Commission, The Business Roundtable, The French American Business Council and Royal Ahold. He was United States Chair of the 1998 TransAtlantic Business Dialogue (TABD) and in 1990 was appointed to the President's Export Council. Currently, Mr. De Vink serves as Member of Sotheby's International Advisory Board, Member of the Board of Alcon, Inc., Member of European Advisory Council of Rothschild & Cie., Member of the Board of Flamel Technologies and Member of the Board of Stiefel Laboratories Inc.
Oeri, Andreas Dr. Andreas Oeri has been Non-Executive Director at Roche Holding Ltd. since 1996. In addition, he acts as Chairman of the Corporate Governance and Sustainability Committee of the Company. Dr. Oeri completed Medical Studies at Universitaet Basel and holds a Swiss Medical Diploma as well as a Doctorate of Medicine. From 1997 until 1985, he worked as Assistant Physician in the Surgical Clinic of the Cantonal Hospital (Kantonsspital) in Liestal, the Institute for Physical Medicine of the Cantonal Hospital (Kantonsspital) in Basel, the Surgical Department of the University of Basel and Basel University Orthopedic Hospital. From 1986 until 1988, Dr. Oeri was Acting Senior Physician of the Basel University Orthopedic Hospital. In 1988 he became a Specialist in Orthopedic Surgery (FMH). Since 1988, he has had his own practice for Orthopedic Surgery in Basel.
Julius, DeAnne Dr. DeAnne Julius has been Non-Executive Director at Roche Holding Ltd. since 2002. In addition, she acts as Chairwoman of the Audit Committee of the Company. She holds an Master of Arts degree as well as a Doctorate (Ph.D.) degree in Economics from the University of California and a Bachelor of Science degree in Economics from Iowa State University. Dr. Julius also holds Honorary Degrees from the University of Warwick, the University of Birmingham, Southbank University and the University of Bath (United Kingdom). From 1970 until 1971, she was Economic Analyst the United States Government Civil Service, Washington DC. From 1972 until1975, she was Lecturer and Teaching Assistant at the University of California. From 1975 until 1982, Dr. Julius was Economic Advisor at the World Bank, Washington DC. From 1983 until 1986, she was Managing Director at Logan Associates Inc, Washington DC and London. From 1986 until 1989, she was Director of the International Economics Program at the Royal Institute of International Affairs (Chatham House), London. From 1989 until 1993, she was Chief Economist at the Royal Dutch Shell Group, London. From 1993 until 1997, Dr. Julius was Chief Economist at British Airways PLC, London. From 1997 until 2001, she was Member of the Monetary Policy Committee of the Bank of England. From 2001 until 2004, she was Member of the Court of Bank of England. Since 2003, Dr. Julius has been Chairman of the Royal Institute of International Affairs. Moreover, she is also Non-Executive Director of BP, Vice President of the Society of Business Economists and Non-Executive Member of the Board of Directors of Jones Lang LaSalle Inc.
Burns, William Mr. William M. Burns has been nominated for the election as Non-Executive Director at Roche Holding Ltd. as of March 2, 2010. He served as Member of the Corporate Executive Committee and Chief Executive Officer of the Division Roche Pharmaceuticals at Roche Holding Ltd. from January 1, 2005 till December 31, 2009. Mr. Burns started his career in 1969 with Beecham Pharmaceuticals. In 1986, he became Director of Sales and Marketing for Roche UK. In 1988, he became Head of Pharmaceuticals Division at Roche UK. In 1991, he became Global Head of Strategic Marketing and Business Development at F. Hoffmann-La Roche Ltd, Basel. In 1998, Mr. Burns became Head of Europe/International. In 2000, he became Member of the Corporate Executive Committee of the Roche Group. In 2001, he became Head of the Pharmaceuticals Division. In 2002, Mr. Burns became Board Member of Chugai Pharmaceuticals, Japan, a Roche Subsidiary. In 2004, he became Board Member of Genentech, United States of America, a Roche Subsidiary. He studied at the University of Strathclyde, where Mr. Burns gained a Bachelor of Art (Honors Degree).
Weder di Mauro, Beatrice Prof. Dr. Beatrice Weder di Mauro has been Non-Executive Director at Roche Holding Ltd. since 2006. In addition, she acts as Member of the Corporate Governance and Sustainability Committee as well as Audit Committee of the Company. She studied at Universitaet Basel, Department of Economics, where she gained a Doctorate (Ph.D.) degree in 1993. Prof. Dr. Weder di Mauro was named Young Global Leader at World Economic Forum at Davos at the World Economic Forum in Geneva and received an award for Outstanding Research in 1999 from the Regierungsrat Basel-Stadt. From 1993 until 1994, she was Post-Doctoral Research Fellow at the University of Basel. From 1994 until 1996, she was Economist at the International Monetary Fund, Washington D.C. From 1996 until 1997, Prof. Dr. Weder di Mauro was Economist at the World Bank, Washington D.C. From 1997 until 1998, she was Research Fellow at the United Nations University, Tokyo. From 1998 until 2001, she was Assistant Professor of Economics at the University of Basel. Since 2001, she has been Professor of Economics at the University of Mainz and since 2004, Prof. Dr. Weder di Mauro has been Member of the German Council of Economic Experts. She was Member of the Board of Macroeconomic Advisors of the Swiss Federation from 2002 until 2004. From 2001 until 2004, she was Member of the Scientific Advisory Board of the Institute for Economic Research (HWWA) in Hamburg. From 2002 until 2004, she was Co-Editor of Applied Economics Quarterly in Berlin. Prof. Dr. Weder di Mauro is Member of the Supervisory Board of ERGO Insurance Group since 2005. Since 2003, she has been Research Fellow at the Center For Economic Policy Research and since 2005, she has been Member of the Steering Committee of the Group: The Macroeconomics of Global Interdependence. She is Member of Committee on International Economics of the Verein fuer Socialpolitik since 2005. Prof. Dr. Weder di Mauro is Research Fellow at the Center for Financial Studies in Frankfurt since 1999.
Baschera, Pius Prof. Dr. Pius Baschera has been Non-Executive Director at Roche Holding Ltd. since March 5, 2007. He is Member of the Corporate Governance and Sustainability Committee of the Company. He studied Mechanical Engineering with Scientific Management at the Swiss Federal Institute of Technology in Zurich, where he gained a Doctorate and became Titular Professor. From 1979 until 1981, Prof. Dr. Baschera was Vice President Production Controlling at Hilti Corporation, Schaan. From 1982 until 1984, he was Vice President Corporate Development Western Hemisphere at Hilti Inc. Tulsa, in the United States of America. In 1985, he was General Manager of Hilti (Switzerland) AG and from 1985 until 1989, General Manager of Hilti Deutschland GmbH. From 1989 until 1990, Prof. Dr. Baschera was Vice President Market Region Europe 1 at Hilti Corporation, Schaan, where he then worked as Member of Executive Board and Chief Financial Officer from 1990 until 1993 and Chief Executive Officer from 1994 until 2006. He then became Hilti Corporation’s Chairman of the Board of Directors in 2007. Currently, Prof. Dr. Baschera also serves as Member of Advisory Board of Vorwerk as well as Ardex GmbH, as Chairman of the Board of Directors of Venture Incubator AG and as Member of Board of Directors of Schindler Holding AG.
Ruttenstorfer, Wolfgang Dr. Wolfgang Ruttenstorfer has been Non-Executive Director at Roche Holding Ltd. since March 5, 2007. In addition, he acts as Member of the Audit Committee of the Company. He holds a Doctorate in Economics and Business Administration from Wirtschaftsuniversitaet Wien (University of Economics and Business Administration Vienna). From 1976 until 1984, Dr. Ruttenstorfer worked as a Controller at OMV. From 1985 until 1989, he was Head of Planning and Strategic Development. From 1990 until 1992, he was Head Marketing and the distribution of mineral oil products. From 1992 until 1996, Dr. Ruttenstorfer was Member of the Executive Board of Directors, responsible for Finance, Controlling and Chemical. From 1996 until 1997, he was Member of the Executive Board of Directors, responsible for Exploration & Production, Natural Gas & Chemical. From 1997 until 1999, he worked at the Austrian Federal Ministry of Finance as Secretary of State (Deputy Minister), responsible for Economic and Monetary Union, International Financial Institutions, capital markets and public services. From 2000 until 2002, Dr. Ruttenstorfer was Deputy Chairman, responsible for Gas and Chemicals at OMV, where he has been Chief Executive Officer and Chairman of the Executive Board since 2002. In 1998, he became Chairman of the Board of Governors of the International Monetary Fund and the World Bank Group and Chairman of the EU-Budget Council during Austria’s EU-Presidency.
Levinson, Arthur Dr. Arthur D. Levinson has been nominated for the election as Non-Executive Director at Roche Holding Ltd. as of March 2, 2010. He occupies the position of Chairman of the Board of Directors at Genentech, Inc.

Basic Compensation

Name Fiscal Year Total
Schwan, Severin 2,875,000
Humer, Franz 15,117,000
Gerber, Fritz --
Hunziker, Erich 2,000,000
Hoffmann, Andre 400,000
Gehrig, Bruno 400,000
Keller, Gottlieb 1,500,000
Kissling, Rene --
Ayyoubi, Silvia 725,004
Soriot, Pascal 1,246,880
O'Day, Daniel --
Bell, John 330,000
Frey, Walter 360,000
De Vink, Lodewijk 330,000
Oeri, Andreas 360,000
Julius, DeAnne 360,000
Burns, William 2,000,000
Weder di Mauro, Beatrice 360,000
Baschera, Pius 330,000
Ruttenstorfer, Wolfgang 330,000
Levinson, Arthur --
As Of 30 Dec 2009

Insider Trading

» Full list on Insider Trading
view people for: